BNP Paribas Financial Markets
YMAB

BNP Paribas Financial Markets’s Y-mAbs Therapeutics YMAB Stock Holding History

BNP Paribas Financial Markets’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-94,383
Closed -$426K – 5806
2025
Q2 		$426K Sell
94,383
-1,119
-1% -$5.03K ﹤0.01% 3424
2025
Q1 		$423K Buy
95,502
+90,628
+1,859% +$526K ﹤0.01% 3285
2024
Q4 		$38.2K Sell
4,874
-21,545
-82% -$262K ﹤0.01% 4533
2024
Q3 		$347K Sell
26,419
-537
-2% -$6.81K ﹤0.01% 3011
2024
Q2 		$326K Sell
26,956
-7,919
-23% -$107K ﹤0.01% 2871
2024
Q1 		$567K Sell
34,875
-299
-0.9% -$4.03K ﹤0.01% 2773
2023
Q4 		$240K Buy
35,174
+21,681
+161% +$125K ﹤0.01% 3133
2023
Q3 		$73.5K Buy
13,493
+3,896
+41% +$22.7K ﹤0.01% 3396
2023
Q2 		$65.2K Sell
9,597
-25,907
-73% -$194K ﹤0.01% 3397
2023
Q1 		$178K Buy
35,504
+1,108
+3% +$4.52K ﹤0.01% 3183
2022
Q4 		$168K Sell
34,396
-4,615
-12% -$33.5K ﹤0.01% 3063
2022
Q3 		$563K Buy
39,011
+31,031
+389% +$514K ﹤0.01% 2901
2022
Q2 		$121K Buy
7,980
+5,052
+173% +$58.9K ﹤0.01% 3291
2022
Q1 		$34.8K Sell
2,928
-6,172
-68% -$63.4K ﹤0.01% 3625
2021
Q4 		$148K Buy
9,100
+2,651
+41% +$56.7K ﹤0.01% 3483
2021
Q3 		$184K Buy
6,449
+4,921
+322% +$155K ﹤0.01% 3068
2021
Q2 		$51.6K Sell
1,528
-8,737
-85% -$280K ﹤0.01% 3251
2021
Q1 		$310K Sell
10,265
-57,640
-85% -$2.36M ﹤0.01% 2834
2020
Q4 		$3.36M Buy
67,905
+60,856
+863% +$2.81M 0.01% 1349
2020
Q3 		$271K Buy
7,049
+4,912
+230% +$195K ﹤0.01% 2584
2020
Q2 		$92.3K Sell
2,137
-8,198
-79% -$310K ﹤0.01% 2799
2020
Q1 		$270K Buy
10,335
+7,591
+277% +$220K ﹤0.01% 2702
2019
Q4 		$85.8K Sell
2,744
-64
-2% -$1.89K ﹤0.01% 3358
2019
Q3 		$73.2K Buy
2,808
+1,953
+228% +$49.9K ﹤0.01% 3287
2019
Q2 		$19.6K Sell
855
-592
-41% -$13.6K ﹤0.01% 3907
2019
Q1 		$37.9K Buy
+1,447
New +$31.8K ﹤0.01% 3663

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BNP Paribas Financial Markets's YMAB Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 94,383 shares — an estimated $426K sold.

BNP Paribas Financial Markets first reported a position in YMAB in Q1 2019 and held it in 26 quarters. The position peaked at $3.36M in Q4 2020. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 94,383 Y-mAbs Therapeutics shares in Q3 2025, an estimated $426K.
  • BNP Paribas Financial Markets first reported a position in Y-mAbs Therapeutics in Q1 2019 and held it in 26 quarters.
  • BNP Paribas Financial Markets's Y-mAbs Therapeutics position peaked at $3.36M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.